Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Paeds SAQsgenetics-dysmorphology-and-metabolism

Paeds SAQs · genetics-dysmorphology-and-metabolism

Peroxisomal disorders — formative SAQs

Formative SAQs on the peroxisomal disorders: splitting the bedside pattern into the biogenesis group (Zellweger spectrum) and the single-enzyme group (X-linked adrenoleukodystrophy), confirming with a plasma very-long-chain fatty acid panel, and matching the disease-modifying therapy to the disorder and the pace.

20 marks30 min3 min readVerification in progress

Target exams

RACP General PaediatricsRACP DWEMRCPCH Clinical
On this page
Study tools

Target exams

RACP General PaediatricsRACP DWEMRCPCH Clinical
Prompt
Peroxisomal disorders across the neonate and the school-age boy

Question 1 (10 marks)

A term neonate is born with a high forehead, a large anterior fontanelle, a broad nasal bridge, and profound hypotonia. Feeding is poor, and within days the infant develops seizures that are hard to control. The liver is enlarged, the skin is mildly jaundiced, and a skeletal survey shows stippled epiphyses. [1] [2]

(a) Give a unifying diagnosis and name the mechanistic group it belongs to. (2 marks) [2]

(b) Outline the confirmatory investigation strategy, naming the single most useful first-line blood test and the expected biochemical signature. (4 marks) [1] [2]

(c) Describe the disease-directed therapy and the multidisciplinary supportive care this infant will need. (4 marks) [2]

Model answer

The unifying diagnosis is a peroxisome biogenesis disorder in the Zellweger spectrum, most likely severe neonatal Zellweger syndrome given the dysmorphism, profound hypotonia, seizures, hepatomegaly with cholestasis, and chondrodysplasia punctata. The mechanistic group is the biogenesis disorders, caused by recessive mutations in the PEX genes that prevent functional peroxisomes from assembling. [2]

The single most useful first-line test is the plasma very-long-chain fatty acid panel, with the C26:0 level and the C26-to-C22 ratio. In a biogenesis disorder the abnormality is global: very-long-chain fatty acids are elevated, phytanic acid and pristanic acid are elevated, and bile-acid intermediates are elevated, while red-cell plasmalogens are deficient. Molecular testing of the PEX gene panel confirms the diagnosis, defines the variant, and enables family testing and prenatal diagnosis. [1] [2]

Disease-directed therapy is cholic acid, which replaces the missing end-product of peroxisomal bile-acid synthesis and reduces the toxic intermediates. Supportive care is multidisciplinary: fat-soluble vitamin supplementation, seizure control, feeding and growth support with possible gastrostomy, management of cholestasis and liver dysfunction, hearing aids or cochlear implantation, and vision rehabilitation. The prognosis for the severe end is guarded, and early, open goals-of-care discussion with the family is part of the management. [2]

Paediatrics Fellowship Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Paediatrics Fellowship fellowship library.

Sign in to continueSee pricing
References4ShowHide
  1. [1]Wanders RJA, Waterham HR. Biochemistry of mammalian peroxisomes revisited. Annu Rev Biochem, 2006.PMID 16756494
  2. [2]Klouwer FCC, Berendse K, Engelen M, et al. Zellweger spectrum disorders: clinical overview and management approach. Orphanet J Rare Dis, 2015.PMID 26627182
  3. [3]Moser HW, Mahmood A, Raymond GV. X-linked adrenoleukodystrophy. Nat Clin Pract Neurol, 2007.PMID 17342190
  4. [4]Raymond GV, Moser AB, Fatemi A. X-linked adrenoleukodystrophy. GeneReviews, 1993.PMID 20301491
Paediatrics Fellowship Pro

$29/ monthor $279 / year

The complete Paediatrics Fellowship library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousOrganic acidaemias — formative SAQsgenetics-dysmorphology-and-metabolismNextPrader-Willi and Angelman syndromes — formative SAQsgenetics-dysmorphology-and-metabolism